HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A randomized, double-blind, placebo-controlled ascending dose tolerance study of 619C89 in acute stroke.

AuthorsK W Muir, K R Lees, S J Hamilton, C F George, S F Hobbiger, M W Lunnon
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 765 Pg. 328-9 (Sep 15 1995) ISSN: 0077-8923 [Print] United States
PMID7486634 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Neuroprotective Agents
  • Piperazines
  • Placebos
  • Pyrimidines
  • sipatrigine
Topics
  • Cerebrovascular Disorders (drug therapy, physiopathology)
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Humans
  • Infusions, Intravenous
  • Neuroprotective Agents (administration & dosage, therapeutic use, toxicity)
  • Piperazines (administration & dosage, therapeutic use, toxicity)
  • Placebos
  • Pyrimidines (administration & dosage, therapeutic use, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: